Upgrading Dimensions · Expanding Horizons · Shaping the Future | Hillgene 2026 Spring Gala Successfully Concluded

As spring ushers in a new beginning, everything is renewed with vitality. On March 6, 2026, Hillgene successfully held its Spring Gala themed “Upgrading Capabilities · Expanding Horizons · Shaping the Future”.

The event brought together colleagues and partners who have journeyed alongside us, offering a moment to reflect on the achievements of the past year while looking ahead to the opportunities and challenges of the future.

As the lights dimmed and visuals unfolded, memorable moments from the past year were brought to life. From perseverance during difficult times to the joy of shared achievements; from close collaboration among teams to breakthroughs driven by innovation—each moment reflected the dedication and passion of the Hillgene team.

Opening Remarks from Chairman Dr. Lihongjian Li

Dr. Lihongjian Li, Chairman of Hillgene, delivered the opening address, offering insights into the current complex global market environment while expressing sincere appreciation to employees working across different regions.

He emphasized that Hillgene has built a truly global team, with colleagues working across multiple regions worldwide. During the event, while many team members gathered onsite, several overseas employees also joined the celebration remotely—including colleagues working in regions currently experiencing geopolitical uncertainty. Team members from different regions shared perspectives on local healthcare markets, emerging medical trends, and the evolving landscape of the biopharmaceutical industry.

Dr. Li also highlighted Hillgene’s continued commitment to building an integrated CDMO platform for cell and gene therapy, providing all-in-one solutions that support partners from early-stage research to process development and manufacturing. By combining global collaboration with technological innovation, Hillgene aims to further contribute to the advancement of the life sciences industry worldwide.

Address from Co-Chairman Academician Dan Zhang

Co-Chairman Academician Dan Zhang shared his perspective on the evolving landscape of the biopharmaceutical industry and highlighted the growing importance of artificial intelligence in biomedical research and development. He noted that with the rapid advancement of AI technologies, traditional drug discovery and development models are undergoing profound transformation, enabling greater efficiency and opening new pathways for scientific innovation.

Academician Zhang also expressed strong recognition of Hillgene’s continuous innovation in cell technology, particularly acknowledging the value of its K562-based products in supporting research in cell therapy and immunotherapy. These technologies, he noted, are providing important tools for scientists and institutions exploring next-generation therapeutic approaches.

In addition, Academician Zhang shared his confidence in the future of the cell therapy industry. As technologies continue to advance and the industry ecosystem matures, cell-based therapies are expected to play an increasingly important role in addressing complex diseases and expanding the possibilities of modern medicine.

Outstanding Employee Recognition

The evening also featured the Outstanding Employee Recognition Ceremony, celebrating individuals whose contributions have played an important role in the company’s continued growth. Chairman Li and Academician Zhang presented awards to the honorees, recognizing their dedication, professionalism, and commitment to excellence.

Annual Top Sales Award

Outstanding Employee Award

Performances and Celebrations

A variety of performances brought vibrancy and creativity to the evening.

The opening light-and-shadow show "Digital Expansion, Illuminating the World" created an immersive experience with stunning visual effects, winning warm applause. Creative dances including "The Elegant Penguin Dance" highlighted the team’s artistic talent, while "Blue-and-White Porcelain" conveyed elegant cultural charm. Songs such as "Contentment" and "Our Tomorrow" brought warmth and inspiration to the audience. These wonderful acts formed a lively audiovisual feast that embodied creativity and team spirit.

The lucky draw boosted the joyful atmosphere, with prizes bringing surprise and good wishes. The smiles of winners became unforgettable highlights of the night.

Colleagues gathered for a festive banquet, toasting and sharing laughter together. Against soft music, the Spring Gala came to a warm and memorable close, strengthening the cohesion of the Hillgene team.

The gala was not only a celebration of shared achievements but also a start to a new journey.

Looking ahead to 2026, Hillgene will move forward with renewed energy and determination—expanding global cooperation, enhancing CDMO capabilities, and building All-in-One integrated solutions that offer one-stop support for R&D, commercial manufacturing, quality control, and regulatory submission in cell and gene therapy to drive innovation across the life sciences industry.

From advanced research tools such as K562-based feeder cell solutions to integrated development and manufacturing services, Hillgene is committed to accelerating advances in cell therapy and immunotherapy worldwide.